Join
Live feed
·
INSIDERFilingvia Quantisnow
Olema Pharmaceuticals Inc. logo

Director Harmon Cyrus was granted 29,250 shares and sold $147,956 worth of shares (16,393 units at $9.03), increasing direct ownership by 2% to 764,140 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OLMA· Olema Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OLMA (Olema Pharmaceuticals Inc.) and more on Quantisnow.